Tempus AI EBITDA Margin 2023-2025 | TEM
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Tempus AI (TEM) over the last 10 years. The current EBITDA margin for Tempus AI as of March 31, 2025 is .
| Tempus AI EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.80B | $-0.65B | -81.22% |
| 2024-12-31 | $0.69B | $-0.65B | -93.23% |
| 2024-09-30 | $0.64B | $-0.63B | -97.82% |
| 2024-06-30 | $0.60B | $-0.62B | -103.86% |
| 2024-03-31 | $0.56B | $-0.13B | -23.31% |
| 2023-12-31 | $0.53B | $-0.13B | -25.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $10.574B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.605B | 59.29 |
| Hims & Hers Health (HIMS) | United States | $11.194B | 116.30 |
| Doximity (DOCS) | United States | $11.153B | 51.63 |
| IRhythm Technologies (IRTC) | United States | $4.258B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.817B | 59.65 |
| Hinge Health (HNGE) | United States | $3.642B | 0.00 |
| Privia Health (PRVA) | United States | $2.447B | 167.25 |
| Schrodinger (SDGR) | United States | $1.671B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.639B | 0.00 |
| 10x Genomics (TXG) | United States | $1.600B | 0.00 |
| Phreesia (PHR) | United States | $1.595B | 0.00 |
| Enovis (ENOV) | United States | $1.556B | 8.68 |
| Azenta (AZTA) | United States | $1.507B | 70.04 |
| Omnicell (OMCL) | United States | $1.324B | 23.35 |
| Evolent Health (EVH) | United States | $1.147B | 97.70 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.567B | 0.00 |
| Standard BioTools (LAB) | United States | $0.517B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.435B | 130.00 |
| TruBridge (TBRG) | United States | $0.336B | 745.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.274B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
| CapsoVision (CV) | United States | $0.204B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.173B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.158B | 0.00 |
| Pulmonx (LUNG) | United States | $0.130B | 0.00 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.078B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |